Iovate Health Sciences Enters Negotiated Settlement on Advertising

Wednesday, July 14, 2010 Corporate News J E 4

WASHINGTON, July 14 /PRNewswire/ -- Iovate Health Sciences is pleased to have reached an agreed settlement with the Federal Trade Commission involving advertising for certain products.  These products -- Cold MD, Germ MD, Allergy MD, Accelis, and nanoSlim -- have long been discontinued, some as far back as 2007.  The agreement reached between Iovate and the FTC, which admits no wrongdoing, sets new, clearer standards for substantiating health-related advertising claims.  Iovate is prepared to conduct business in compliance with the new standards and remains committed to providing only the highest quality products to its valued customers to help them meet their health and fitness goals.

SOURCE Iovate Health Sciences



You May Also Like

View All

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
User Avatar
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions
Mylan Receives Approval for Nabumetone Tablets
Northwest Georgia Oncology Centers Joins United Ne...